Cynthia Duncan
Psychiatric/Mental Health · Tyrone, GANPI 1972671634
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 303 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,428, 2.2 times the $641 reported in 2021. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 303 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$872
- AbbVie$867
- Teva Pharmaceuticals USA, Inc.$453
- Otsuka America Pharmaceutical, Inc.$378
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$365
- Neos Therapeutics, LP$354
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,50999%
- Education$491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 44 | $872 |
| AbbVie | 70 | $867 |
| Teva Pharmaceuticals USA, Inc. | 23 | $453 |
| Otsuka America Pharmaceutical, Inc. | 17 | $378 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $365 |
| Neos Therapeutics, LP | 18 | $354 |
| Supernus Pharmaceuticals, Inc. | 18 | $308 |
| Alkermes, Inc. | 14 | $299 |
| Neurocrine Biosciences, Inc. | 9 | $260 |
| Collegium Pharmaceutical, Inc. | 9 | $152 |
| Alfasigma USA, Inc. | 8 | $152 |
| Ironshore Pharmaceuticals Inc. | 7 | $150 |
| Axsome Therapeutics, Inc. | 6 | $147 |
| Tris Pharma Inc | 7 | $145 |
| Sunovion Pharmaceuticals Inc. | 8 | $144 |
| Noven Therapeutics, LLC | 6 | $123 |
| Vanda Pharmaceuticals Inc. | 5 | $85 |
| Idorsia Pharmaceuticals US Inc | 4 | $83 |
| Lundbeck LLC | 3 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Bausch Health US, LLC | 2 | $37 |
| Adlon Therapeutics L.p. | 2 | $28 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
How this compares
$5,558 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 31 | $352,703 |
| VraylarCariprazine Hcl | 13 | $31,925 |
| CaplytaLumateperone Tosylate | 11 | $22,854 |
| BelsomraSuvorexant | 12 | $7,808 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 16 | $1,027 |
| Temazepam | 13 | $899 |
| Buspirone Hcl | 26 | $862 |
| Trazodone Hcl | 37 | $511 |
| Lamotrigine | 32 | $373 |
| Bupropion XlBupropion Hcl | 27 | $357 |
| Clonazepam | 20 | $324 |
| Eszopiclone | 15 | $311 |
| Mirtazapine | 11 | $268 |
| Duloxetine Hcl | 28 | $226 |
| Sertraline Hcl | 28 | $168 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $453 | $352,70331 claims |
| AbbVieVraylar | $867 | $31,92513 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $365 | $22,85411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Tyrone
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
- Matthew DowdyWoodstock$25K
- Natasha GilesLoganville$21K
- Darrick SealeyWarner Robins$17K
- Olufunke AdewunmiSmyrna$13K
- Bradley MosherSuwanee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.